Company intelligence / Profile preview

Lemon

Cambridge, Massachusetts, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Lemonade Bio is a synthetic biology company focused on engineering novel proteins for therapeutic and industrial applications. Leveraging a proprietary platform that combines generative AI with high-throughput screening, the company aims to design proteins with optimized functions that are difficult to achieve through traditional methods. The company was founded by experts in protein design and synthetic biology, including former members of Ginkgo Bioworks. Lemonade Bio operates primarily in the pre-clinical stage, developing a suite of tools to accelerate the discovery and optimization of protein-based drugs.

Modalities: ProteinSynthetic biology
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Lemon.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lemon.

Explore the full profile